St Germain D J Co Inc
Source: SEC Form 13F · as of Mar 2026St Germain D J Co Inc holds 8 biotech & pharma companies tracked by BioSniper, totaling $3.5M in value as of Mar 2026 (SEC Form 13F).
Companies held
8
Total value held
$3.5M
BioSniper AIPage context preserved
Prepared research question
What matters most for ALNYLAM PHARMACEUTICALS, INC. (ALNY)—catalysts, financial risk and supporting evidence?
Run cited research
Traceable citations · Unknowns marked
| Company | Shares | Value |
|---|---|---|
| ALNYALNYLAM PHARMACEUTICALS, INC. | 7,852 | $2.6M |
| GILDGILEAD SCIENCES, INC. | 2,724 | $380K |
| SNYSanofi | 7,005 | $338K |
| BEAMBeam Therapeutics Inc. | 3,500 | $83K |
| JAZZJazz Pharmaceuticals plc | 324 | $61K |
| GSKGSK plc American Depositary Shares (Each representing two Ordinary Shares) | 1,064 | $59K |
| LGNDLigand Pharmaceuticals Incorporated | 75 | $15K |
| OGNOrganon & Co. | 711 | $4K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.